Sort
326,823 grants matching “clinical trial”
Cold Chain-Independent, Needle-Free Mucosal Virosomal Vaccine to Prevent HIV-1 Acquisition at Mucosal Levels
$1,719,534Ruth Margrit Ruprecht · University Of Louisiana At Lafayette · U19 · FY2021 · AI
Development/Production-Alternative Serotype HIV Recombinant Adenoviral Vaccine
$1,719,454Kimberly Wallace · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Data Acquisition and Analysis Core
$1,719,292Sara Jane Webb · Yale University · U19 · FY2017 · MH
Craniofacial Anomalies and Regeneration
$1,719,278Janice Lee · National Institute Of Dental & Craniofacial Research · ZIA · FY2024 · DE
Michigan Alzheimer's Disease Core Center
$1,719,170Henry L Paulson · University Of Michigan At Ann Arbor · P30 · FY2016 · AG
Perimenopause in Brain Aging and Alzheimer's Disease
$1,719,120Roberta Diaz Brinton · University Of Southern California · P01 · FY2011 · AG
Boston OAIC: A Translational Approach to Function Promoting Therapies
$1,718,896Shalendar Bhasin · Brigham And Women'S Hospital · P30 · FY2023 · AG
The University of Kansas Cancer Center's- MCA Rural NCORP
$1,718,770Gary C. Doolittle · University Of Kansas Medical Center · UG1 · FY2024 · CA
The University of Kansas Cancer Center's- MCA Rural NCORP- extension
$1,718,770Gary C. Doolittle · University Of Kansas Medical Center · UG1 · FY2025 · CA
1/2 PROSpect: Prone and Oscillation Pediatric Clinical Trial (CCC)
$1,718,755Martha Aq Curley · University Of Pennsylvania · UG3 · FY2018 · HL
Michigan Alzheimer's Disease Core Center
$1,718,713Henry L Paulson · University Of Michigan At Ann Arbor · P30 · FY2019 · AG
New therapeutic vulnerabilities in breast cancer
$1,718,646Kornelia Polyak · Dana-Farber Cancer Inst · P01 · FY2022 · CA
New therapeutic vulnerabilities in breast cancer
$1,718,646Kornelia Polyak · Dana-Farber Cancer Inst · P01 · FY2023 · CA
Soft Tissue Sarcoma Program Project
$1,718,617Samuel Singer · Sloan-Kettering Inst Can Research · P01 · FY2007 · CA
Vanderbilt Meharry Center for AIDS Research
$1,718,609Richard T D'aquila · Vanderbilt University · P30 · FY2009 · AI
Energetics & Breast Cancer: Obesity, Inflammation, Insulin Resistance & Risk
$1,718,471Ruth E Patterson · University Of California, San Diego · U54 · FY2013 · CA
AIDS CLINICAL TRIALS UNIT
$1,718,471University Of Pennsylvania · U01 · FY2002 · AI
REGULATION OF ANGIOGENESIS
$1,718,285Children'S Hospital Boston · P01 · FY2000 · CA
Administrative Core
$1,718,108Rima F Kaddurah-Daouk · Duke University · U19 · FY2022 · AG
Physical and Biological Determinants for Optimal PDT
$1,717,986Massachusetts General Hospital · P01 · FY2001 · CA
Vanderbilt Genome-Electronic Records Project
$1,717,974Dan M Roden · Vanderbilt University · U01 · FY2010 · HG
Multi-functional anti-thrombotic therapy for coronary microvascular obstruction
$1,717,926Ridong Chen · Apt Therapeutics, Inc. · R44 · FY2025 · HL
Clinical and Laboratory Studies of Malignant Lymphomas
$1,717,701Ronald Levy · Stanford University · P01 · FY2009 · CA
Circumventing barriers to effective oncolytic virotherapy of malignant gliomas
$1,717,653E. Antonio Chiocca · Brigham And Women'S Hospital · P01 · FY2019 · CA
Intracellular organelle deficits driving Alzheimer's disease
$1,717,584Grace E. Stutzmann · Rosalind Franklin Univ Of Medicine & Sci · RF1 · FY2020 · AG